This is a cell line derived from the human B-lymphocyte Raji cell line (ATCC® CCL-86TM).
This is a cell line derived from the human B-lymphocyte Raji cell line (ATCC® CCL-86TM). Parental Raji cells were transduced with LV-SFFV-Luc2-P2A-Puro (Imanis #LV012) encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter and linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide. Selection was carried out using puromycin and a methylcellulose-based semi-solid medium.
*The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection.
This cell line has tested negative for mycoplasma contamination.
Cell morphology (200x)
The indicated number of cells were placed in wells of a 96-well plate. After the addition of 3 mg/mL d-luciferin, the plate was immediately imaged using an IVIS Spectrum. The total flux (photons/sec) was plotted as a function of cell number.
Raji-Fluc-Puro (green) cells were stained with isotype control antibody (grey) or antibody specific to BCMA (top, left), CD19 (top, right), or GPRC5D (bottom) and analyzed by flow cytometry.
Complete Growth Medium: ATCC-formulated RPMI-1640 Medium (RPMI), supplemented with 10% fetal bovine serum (FBS), 1% Penicillin/Streptomycin.
5 µg/mL Puromycin can be added to the growth medium. Puromycin should NOT be added to the medium until a culture has been well established from the thawed cells (about 1 week). It is also recommended that a backup frozen cell stock be generated (see below) before adding puromycin to the growth medium. Caution! Typical commercial puromycin stocks are provided at a concentration of 10 mg/mL or 10,000X.
The cells should be subcultured as needed to maintain a density between 5 x 105 and 2 x 106 cells/mL. The cells can be passaged by dilution in fresh complete growth medium. Regular passage using low-speed centrifugation is recommended to limit the amount of debris in cultures.
These cells are suitable for in vitro and in vivo experimentation.
The luciferase transgene facilitates in vivo noninvasive bioluminescent imaging of implanted cells.
These cells were generated via lentiviral vector transduction. The lentiviral vector is a self-inactivating (SIN) vector in which the viral enhancer and promoter have been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without cis-acting effects of the LTR1.
Don’t see what you need in our catalog? Our scientific team engineers cell lines, viral vectors, and assays and provides the characterization data you need to move forward with confidence.
